5 Myalgic Encephalomyelitis Clinical Trials in Loma Linda, CA (2026)

Q: How do I join a clinical trial in Loma Linda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Loma Linda research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Loma Linda

NCT05685745Recruiting

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

The goal of the Tiny Baby Collaborative Multicenter Inventory of Neonatal-Perinatal Interventions (MINI) minimum dataset is to serve as a registry detailing the outcomes and practices for all deliveri...

Loma Linda, CA5,000 participantsThe University of Texas Health Science Center, Houston

View Study Details

NCT05382338Recruiting

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

This phase III trial tests two hypotheses in patients with low-risk and average-risk medulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain. The term, risk, refers t...

Loma Linda, CAPHASE3225 participantsChildren's Oncology Group

View Study Details

NCT02235857Recruiting

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

Liposorber® LA-15 System is a blood purification therapy that selectively removes malignant lipoproteins including low density lipoprotein from circulating blood flow and rapidly reduces the plasma ch...

Loma Linda, CANA35 participantsKaneka Medical America LLC

View Study Details

NCT07020819Recruiting

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

The goal of this open label study is to measure pharmacokinetics, pharmacodynamics, early efficacy, and safety of tanruprubart in adult and pediatric participants, in the United States, Canada, and Eu...

Loma Linda, CAPHASE330 participantsAnnexon, Inc.

View Study Details

NCT07157787Recruiting

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

The primary objective of this study is to evaluate the efficacy of ALXN1920 compared with placebo in participants with PMN who are at a high risk for disease progression using 24-hour urine protein cr...

Loma Linda, CAPHASE230 participantsAlexion Pharmaceuticals, Inc.

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Loma Linda

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 5 myalgic encephalomyelitis clinical trials recruiting participants in Loma Linda, CA. These studies are seeking a combined 5,320 participants. Research is being sponsored by The University of Texas Health Science Center, Houston, Children's Oncology Group, Kaneka Medical America LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Loma Linda — FAQ

Are there myalgic encephalomyelitis clinical trials in Loma Linda?

Yes, there are 5 myalgic encephalomyelitis clinical trials currently recruiting in Loma Linda, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Loma Linda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Loma Linda research site will contact you about next steps.

Are clinical trials in Loma Linda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Loma Linda studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 5 active trials in Loma Linda are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated October 21, 2026 from ClinicalTrials.gov